Report Detail

Pharma & Healthcare Global TB Disease Vaccine Market Research Report 2022

  • RnM4438741
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 TB Disease Vaccine Market Overview

    • 1.1 Product Overview and Scope of TB Disease Vaccine
    • 1.2 TB Disease Vaccine Segment by Type
      • 1.2.1 Global TB Disease Vaccine Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Prevention Vaccines
      • 1.2.3 Post-exposure Vaccines
      • 1.2.4 Others
    • 1.3 TB Disease Vaccine Segment by Application
      • 1.3.1 Global TB Disease Vaccine Sales Comparison by Application: (2022-2028)
      • 1.3.2 Self-Procurement
      • 1.3.3 UNICEF
      • 1.3.4 Others
    • 1.4 Global TB Disease Vaccine Market Size Estimates and Forecasts
      • 1.4.1 Global TB Disease Vaccine Revenue 2017-2028
      • 1.4.2 Global TB Disease Vaccine Sales 2017-2028
      • 1.4.3 TB Disease Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028

    2 TB Disease Vaccine Market Competition by Manufacturers

    • 2.1 Global TB Disease Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global TB Disease Vaccine Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global TB Disease Vaccine Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers TB Disease Vaccine Manufacturing Sites, Area Served, Product Type
    • 2.5 TB Disease Vaccine Market Competitive Situation and Trends
      • 2.5.1 TB Disease Vaccine Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest TB Disease Vaccine Players Market Share by Revenue
      • 2.5.3 Global TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 TB Disease Vaccine Retrospective Market Scenario by Region

    • 3.1 Global TB Disease Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global TB Disease Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America TB Disease Vaccine Market Facts & Figures by Country
      • 3.3.1 North America TB Disease Vaccine Sales by Country
      • 3.3.2 North America TB Disease Vaccine Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe TB Disease Vaccine Market Facts & Figures by Country
      • 3.4.1 Europe TB Disease Vaccine Sales by Country
      • 3.4.2 Europe TB Disease Vaccine Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific TB Disease Vaccine Market Facts & Figures by Region
      • 3.5.1 Asia Pacific TB Disease Vaccine Sales by Region
      • 3.5.2 Asia Pacific TB Disease Vaccine Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America TB Disease Vaccine Market Facts & Figures by Country
      • 3.6.1 Latin America TB Disease Vaccine Sales by Country
      • 3.6.2 Latin America TB Disease Vaccine Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
      • 3.6.6 Colombia
    • 3.7 Middle East and Africa TB Disease Vaccine Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa TB Disease Vaccine Sales by Country
      • 3.7.2 Middle East and Africa TB Disease Vaccine Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global TB Disease Vaccine Historic Market Analysis by Type

    • 4.1 Global TB Disease Vaccine Sales Market Share by Type (2017-2022)
    • 4.2 Global TB Disease Vaccine Revenue Market Share by Type (2017-2022)
    • 4.3 Global TB Disease Vaccine Price by Type (2017-2022)

    5 Global TB Disease Vaccine Historic Market Analysis by Application

    • 5.1 Global TB Disease Vaccine Sales Market Share by Application (2017-2022)
    • 5.2 Global TB Disease Vaccine Revenue Market Share by Application (2017-2022)
    • 5.3 Global TB Disease Vaccine Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Merck
      • 6.1.1 Merck Corporation Information
      • 6.1.2 Merck Description and Business Overview
      • 6.1.3 Merck TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Merck TB Disease Vaccine Product Portfolio
      • 6.1.5 Merck Recent Developments/Updates
    • 6.2 Japan BCG Lab
      • 6.2.1 Japan BCG Lab Corporation Information
      • 6.2.2 Japan BCG Lab Description and Business Overview
      • 6.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Japan BCG Lab TB Disease Vaccine Product Portfolio
      • 6.2.5 Japan BCG Lab Recent Developments/Updates
    • 6.3 Serum Institute of India
      • 6.3.1 Serum Institute of India Corporation Information
      • 6.3.2 Serum Institute of India Description and Business Overview
      • 6.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 Serum Institute of India TB Disease Vaccine Product Portfolio
      • 6.3.5 Serum Institute of India Recent Developments/Updates
    • 6.4 AJ Vaccines
      • 6.4.1 AJ Vaccines Corporation Information
      • 6.4.2 AJ Vaccines Description and Business Overview
      • 6.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 AJ Vaccines TB Disease Vaccine Product Portfolio
      • 6.4.5 AJ Vaccines Recent Developments/Updates
    • 6.5 BioFarma
      • 6.5.1 BioFarma Corporation Information
      • 6.5.2 BioFarma Description and Business Overview
      • 6.5.3 BioFarma TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 BioFarma TB Disease Vaccine Product Portfolio
      • 6.5.5 BioFarma Recent Developments/Updates
    • 6.6 GreenSignal Bio Pharma
      • 6.6.1 GreenSignal Bio Pharma Corporation Information
      • 6.6.2 GreenSignal Bio Pharma Description and Business Overview
      • 6.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 GreenSignal Bio Pharma TB Disease Vaccine Product Portfolio
      • 6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
    • 6.7 China National Biotec
      • 6.6.1 China National Biotec Corporation Information
      • 6.6.2 China National Biotec Description and Business Overview
      • 6.6.3 China National Biotec TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 China National Biotec TB Disease Vaccine Product Portfolio
      • 6.7.5 China National Biotec Recent Developments/Updates
    • 6.8 Biomed Lublin
      • 6.8.1 Biomed Lublin Corporation Information
      • 6.8.2 Biomed Lublin Description and Business Overview
      • 6.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 Biomed Lublin TB Disease Vaccine Product Portfolio
      • 6.8.5 Biomed Lublin Recent Developments/Updates
    • 6.9 Taj Pharmaceuticals
      • 6.9.1 Taj Pharmaceuticals Corporation Information
      • 6.9.2 Taj Pharmaceuticals Description and Business Overview
      • 6.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Taj Pharmaceuticals TB Disease Vaccine Product Portfolio
      • 6.9.5 Taj Pharmaceuticals Recent Developments/Updates
    • 6.10 Ataulpho de Paiva
      • 6.10.1 Ataulpho de Paiva Corporation Information
      • 6.10.2 Ataulpho de Paiva Description and Business Overview
      • 6.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 Ataulpho de Paiva TB Disease Vaccine Product Portfolio
      • 6.10.5 Ataulpho de Paiva Recent Developments/Updates
    • 6.11 IVAC
      • 6.11.1 IVAC Corporation Information
      • 6.11.2 IVAC TB Disease Vaccine Description and Business Overview
      • 6.11.3 IVAC TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 IVAC TB Disease Vaccine Product Portfolio
      • 6.11.5 IVAC Recent Developments/Updates
    • 6.12 Queen Saovabha Mem. Inst
      • 6.12.1 Queen Saovabha Mem. Inst Corporation Information
      • 6.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Description and Business Overview
      • 6.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 Queen Saovabha Mem. Inst TB Disease Vaccine Product Portfolio
      • 6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
    • 6.13 Microgen
      • 6.13.1 Microgen Corporation Information
      • 6.13.2 Microgen TB Disease Vaccine Description and Business Overview
      • 6.13.3 Microgen TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 Microgen TB Disease Vaccine Product Portfolio
      • 6.13.5 Microgen Recent Developments/Updates

    7 TB Disease Vaccine Manufacturing Cost Analysis

    • 7.1 TB Disease Vaccine Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of TB Disease Vaccine
    • 7.4 TB Disease Vaccine Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 TB Disease Vaccine Distributors List
    • 8.3 TB Disease Vaccine Customers

    9 TB Disease Vaccine Market Dynamics

    • 9.1 TB Disease Vaccine Industry Trends
    • 9.2 TB Disease Vaccine Market Drivers
    • 9.3 TB Disease Vaccine Market Challenges
    • 9.4 TB Disease Vaccine Market Restraints

    10 Global Market Forecast

    • 10.1 TB Disease Vaccine Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of TB Disease Vaccine by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of TB Disease Vaccine by Type (2023-2028)
    • 10.2 TB Disease Vaccine Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of TB Disease Vaccine by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of TB Disease Vaccine by Application (2023-2028)
    • 10.3 TB Disease Vaccine Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of TB Disease Vaccine by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of TB Disease Vaccine by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:

      The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
      Industry Insights
      Due to the COVID-19 pandemic, the global TB Disease Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe TB Disease Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe TB Disease Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      Prevention Vaccines accounting for % of the TB Disease Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Self-Procurement segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      The global major manufacturers of TB Disease Vaccine include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. In terms of revenue, the global 3 largest players have a % market share of TB Disease Vaccine in 2021.
      This report focuses on TB Disease Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall TB Disease Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
      Key Drivers & Barriers
      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
      Post-covid-19 Outlook
      The readers in the section will understand how the TB Disease Vaccine market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
      Segmental Outlook
      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
      Segment by Type
      Prevention Vaccines
      Post-exposure Vaccines
      Others
      Segment by Application
      Self-Procurement
      UNICEF
      Others
      Regional Outlook
      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Scenario
      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
      Merck
      Japan BCG Lab
      Serum Institute of India
      AJ Vaccines
      BioFarma
      GreenSignal Bio Pharma
      China National Biotec
      Biomed Lublin
      Taj Pharmaceuticals
      Ataulpho de Paiva
      IVAC
      Queen Saovabha Mem. Inst
      Microgen
      Frequently Asked Questions
      Which product segment grabbed the largest share in the TB Disease Vaccine market?
      How is the competitive scenario of the TB Disease Vaccine market?
      Which are the key factors aiding the TB Disease Vaccine market growth?
      Which are the prominent players in the TB Disease Vaccine market?
      Which region holds the maximum share in the TB Disease Vaccine market?
      What will be the CAGR of the TB Disease Vaccine market during the forecast period?
      Which application segment emerged as the leading segment in the TB Disease Vaccine market?
      What key trends are likely to emerge in the TB Disease Vaccine market in the coming years?
      What will be the TB Disease Vaccine market size by 2028?
      Which company held the largest share in the TB Disease Vaccine market?


      Summary:
      Get latest Market Research Reports on TB Disease Vaccine. Industry analysis & Market Report on TB Disease Vaccine is a syndicated market report, published as Global TB Disease Vaccine Market Research Report 2022. It is complete Research Study and Industry Analysis of TB Disease Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,360.60
      4,721.20
      2,784.00
      5,568.00
      374,361.00
      748,722.00
      225,214.00
      450,428.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report